Core Viewpoint - Peloton Minerals Corporation has successfully closed a non-brokered private placement financing, raising a total of $134,100 from the issuance of 1,490,000 units, which will be utilized for lithium exploration and working capital [1][2]. Group 1: Financing Details - The private placement was conducted at a price of CDN$0.09 per unit, with each unit comprising one common share and one common share purchase warrant exercisable at $0.12 for three years [1]. - This placement marks the third tranche under the same pricing terms, bringing the cumulative total raised to $1,170,352.53 [2]. - The company incurred fees amounting to eight percent of the funds raised and issued ten percent of the units as broker warrants, which are exercisable into a unit of the offering at the offering price for sixty months [1]. Group 2: Use of Proceeds - Proceeds from the private placement will be allocated towards lithium exploration in northern Nevada and for general working capital [2]. - The company completed its maiden drilling program on the North Elko Lithium Project in November-December 2025, with results expected by the end of January 2026 [2]. Group 3: Regulatory and Compliance Information - The private placement relied on certain prospectus exemptions, including the Existing Shareholder Exemption, allowing capital raising through securities distribution to existing shareholders [3]. - The securities issued are subject to a hold period of four months and one day from the issuance date [4]. Group 4: Company Overview - Peloton Minerals Corporation holds a 100% interest in the North Elko Lithium Project, which is prospective for lithium and other critical minerals, along with interests in gold and copper projects in Nevada and Montana [6][7]. - The company is a reporting issuer in good standing in British Columbia and Ontario, with common shares listed on the CSE and trading on the OTC QB [5].

Core Viewpoint - Cosigo Resources Ltd. is actively engaged in geological exploration and analysis of conglomerate materials in the Taraira District, with recent bulk sampling and planned drilling to further assess gold potential [1][8][13]. Group 1: Geological Exploration - The company has acquired a 120 kg bulk sample from the "Chicken Coop" conglomerate for analysis, with samples being sent to Vancouver for testing [1]. - Reconnaissance prospecting has identified conglomerate stratum material distinct from previously mined areas, with 14 channel samples analyzed showing varying gold concentrations [2][3]. - Further drilling in 2024 has intercepted what is believed to be the same conglomerate layer, with core samples indicating gold presence [4][6]. Group 2: Analytical Results - Analytical results from channel samples show gold concentrations ranging from <0.015 ppm to 1.558 ppm across various samples, with specific samples highlighted for greater than 0.50 ppm gold [3][4]. - Core samples also indicate gold presence, with some samples showing concentrations as high as 11.3 ppm [6]. Group 3: Future Plans - The company plans to conduct a 4 or 5 drill hole campaign to obtain additional strata samples for better identification and characterization of the conglomerate [8]. - A private placement of up to CAD$1,000,000 has been initiated to fund further prospecting and mapping activities on the Taraira property and other locations [9][11]. Group 4: Company Overview - Cosigo Resources Ltd. is a junior exploration company focused on gold exploration in Colombia and holds interests in properties in Nevada and diamond exploration in Canada [13].

Core Viewpoint - Hybrid Power Solutions Inc. has successfully closed the first tranche of its Life Offering financing, raising gross proceeds of C $1,014,899.94 through the sale of 16,914,999 units at a price of C $0.06 per unit [2]. Financing Details - Each unit consists of one common share and one whole common share purchase warrant, with the warrant exercisable at CDN$0.10 per share for 24 months [3]. - The company may accelerate the expiry of the warrants if the closing price of its common shares reaches or exceeds CDN$0.20 for 20 consecutive trading days [3]. - The offering is conducted under the Listed Issue Financing Exemption, allowing sales to purchasers in Canada (excluding Quebec), the United States, and offshore jurisdictions [4]. Use of Proceeds - The net proceeds from the offering will be allocated for company operations, product and company research and development, sales growth initiatives, marketing, and general corporate purposes [5]. Finder's Fees - The company paid eligible finders a cash fee of 6% of the gross proceeds raised and issued non-transferable finder's warrants, allowing them to acquire shares at a price of $0.10 per share for 24 months [6]. Regulatory Compliance - Completion of the offering is subject to necessary regulatory approvals, including approval from the Canadian Securities Exchange [7]. Company Overview - Hybrid Power Solutions Inc. is a Canadian clean energy innovator focused on developing portable power systems that eliminate the need for fossil fuels in off-grid and remote applications [9][10].

Core Viewpoint - Prismo Metals Inc. has successfully completed an upsized closing of its non-brokered private placement, raising a total of $2,204,000 through the issuance of 22,040,000 units, with plans to fund a drilling program at the Silver King project [1][2]. Group 1: Private Placement Details - The recent closing involved the issuance of 2,940,000 units at an issue price of $0.10 per unit, generating gross proceeds of $294,000 [1]. - The company had previously announced two closings of the private placement, raising $1,745,000 on November 12, 2025, and $165,000 on December 2, 2025 [2]. - Each unit consists of one common share and one common share purchase warrant, with warrants exercisable at $0.175 for 36 months [3]. Group 2: Use of Proceeds - The net proceeds from the private placement will primarily be allocated for drilling at the Silver King project and for general corporate purposes [4]. - The company anticipates accepting additional subscriptions of approximately $75,000 from new shareholders in the coming days [4]. Group 3: Finder's Warrants and Commissions - In connection with the closing, the company issued 185,200 finder's warrants and paid finder's commissions totaling $18,520 [6]. - Each finder's warrant is exercisable for 24 months at a price of $0.10 [6]. Group 4: Company Overview - Prismo Metals Inc. is focused on advancing its Silver King, Ripsey, and Hot Breccia projects in Arizona, as well as its Palos Verdes silver project in Mexico [8].

Core Insights - BioVaxys Technology Corp. has integrated the DPX™ platform into its operations, focusing on organic growth and innovative vaccine development that enhances immune response through a novel mechanism of action [1][5]. Company Developments - The company appointed Dr. James Tartaglia and Dr. Marianne Stanford to its Board and as Scientific Advisor, respectively, enhancing its scientific and business development expertise [2][3][4]. - Dr. Tartaglia has over 34 years of experience in vaccine R&D, having led vaccine development at Sanofi, while Dr. Stanford previously led the development of the DPX™ vaccine portfolio at IMV Inc [3][4]. Clinical Studies - BioVaxys reported positive results from a Phase 1 study of maveropepimut-S (MVP-S) in HR+/HER2- stage II-III breast cancer, showing a significant immune response and a decrease in Ki67 levels from a median of 24% to 6% post-treatment [7][8]. - The company plans to further evaluate MVP-S's systemic immunity and pursue a Phase II study to modify the tumor immune environment in high-risk HR+ breast cancer [9]. Collaborations and Licensing - BioVaxys entered a research agreement with Sona Nanotech to develop new cancer therapeutics combining the DPX platform with Sona's Targeted Hyperthermia Therapy™ [10]. - The company is exploring out-licensing opportunities for MVP-S, particularly for ovarian cancer, and is in discussions with a global pharma company [11][12]. Pipeline Expansion - BioVaxys is advancing its early-stage pipeline with multiple out-licensing opportunities and research collaborations, including a DPX formulation for rabies and a DPX-RSV vaccine that demonstrated antigen-specific immune responses in 93% of subjects [6][14]. - The company is also developing additional infectious disease programs, including DPX-rHA/DPX-FLU for influenza and DPX-rPA for anthrax, with promising preclinical results [15]. Revenue Generation - BioVaxys has revenue-generating licenses with Zoetis Inc. and SpayVac for Wildlife, Inc., focusing on vaccines in the animal health field, with ongoing progress towards commercialization [17][18]. - SpayVac has initiated the regulatory approval process for its immunocontraceptive vaccine targeting feral horses and deer populations, which is based on BioVaxys's technology [18][20]. Future Outlook - The company anticipates aggressive business development activity in 2026, aiming to advance ongoing out-licensing and research collaboration discussions, and to book its first royalty income [22].

Summary of Key Points Core Viewpoint - Headwater Gold Inc. has granted 1,825,000 incentive stock options to its directors, officers, employees, and consultants, which are exercisable at a price of $0.75 for a five-year term and vest immediately [1]. Group 1 - The total number of stock options granted is 1,825,000 [1]. - Each option allows the purchase of one common share at a price of $0.75 [1]. - The options have a term of five years and vest immediately upon grant [1].

Core Viewpoint - Golden Lake Exploration Inc. has entered into a new mining lease agreement with GM Squared, LLC for the Jewel Ridge project in Nevada, which includes both unpatented and patented mining claims, replacing a previous lease from 2004 [1][2]. Lease Agreement Details - The Lease Agreement has a duration of 7 years, requiring annual payments of US$25,000 and a minimum expenditure of US$1 million on mining and exploration activities in the first 3 years [2]. - The Company has the option to purchase the property for US$3 million, deducting the total lease payments made during the agreement [3]. - Upon production commencement, the Company will pay a royalty of 4.0% on net smelter returns, with options to buy down the royalty at specified costs for each percentage point [4]. Termination Conditions - The Company can terminate the Lease Agreement with 30 days written notice, while the Lessor can terminate if the Company defaults on obligations, including payment failures [5]. Additional Claims and Royalties - The Jewel Ridge project includes 19 patented claims (Rainbow Claims) acquired from Greencastle Resources Ltd., subject to a 3.0% royalty, which can be reduced to 1.0% for C$2 million [6]. - In April 2022, the Company added the Lord Byron patented claims, which do not carry any royalties or obligations [7]. - In September 2023, the Company staked an additional 46 unpatented lode claims totaling 924 acres, fully owned without royalty obligations [8]. Company Overview - Golden Lake Exploration Inc. is a junior public mining exploration company focused on mineral exploration and acquisition of mineral property assets [9].

Core Viewpoint - Adamera Minerals Corp. has successfully closed the flow-through portion of its private placement, raising a total of $253,500 through the sale of Flow-Through Units [1][2]. Group 1: Financial Details - The company raised $253,500 from the sale of 3,900,001 Flow-Through Units at a price of $0.065 per unit [2]. - Each Flow-Through Unit consists of one common share and one-half common share purchase warrant, with full warrants exercisable at $0.12 for two years [2]. - The warrants will expire if the closing market price of the common shares reaches $0.16 or more for 10 consecutive trading days, triggering an Accelerated Expiry Date [2]. Group 2: Use of Funds - The funds raised will be allocated for qualifying Canadian exploration expenditures on newly identified gold, copper, and zinc prospects at the South Hedley Project in southern British Columbia [3]. - The financing may be eligible for a 30% Critical Mineral Exploration Tax Credit [3]. Group 3: Related Party Transactions - A director and an officer of the company acquired a total of 507,693 Flow-Through Units under the private placement, constituting a related party transaction [4]. - The company has relied on exemptions from formal valuation and minority shareholder approval requirements due to the transaction's value not exceeding 25% of the company's market capitalization [4]. Group 4: Future Plans - The company plans to close the non-flow-through units of the private placement announced earlier in early 2026 [5]. Group 5: Company Overview - Adamera Minerals Corp. focuses on exploring high-grade gold deposits in Washington State and British Columbia, holding numerous drill-ready targets in areas with past producing mines [5].

Core Viewpoint - Viva Gold Corp. has successfully completed a non-brokered private placement, raising gross proceeds of CDN$4,183,273 through the issuance of 26,145,456 units, which will be utilized for advancing the Tonopah Gold Project [1][2]. Group 1: Offering Details - The Offering consisted of 26,145,456 units priced at CDN$0.16 each, with each unit comprising one common share and one-half of a non-transferable common share purchase warrant [1]. - Each whole warrant is exercisable at CDN$0.24 per share until December 29, 2028, which is 36 months from issuance [1]. - Insiders acquired 6,490,956 units, qualifying as a "related party transaction" but exempt from formal valuation and minority shareholder approval due to the transaction's size relative to the company's market capitalization [3]. Group 2: Use of Proceeds - The proceeds from the Offering will primarily fund pre-feasibility and feasibility studies at the Tonopah Gold Project, including necessary technical and environmental studies [4]. - Additional allocations include geophysical surveys, geological work, and general working capital [4]. Group 3: Finder's Fees - The Company will pay finder’s fees totaling CDN$84,154 and issue 525,962 Finder's Warrants, each exercisable at CDN$0.24 per share until December 29, 2028 [5]. Group 4: Regulatory Approval - The Offering is subject to final approval from the TSX Venture Exchange, and the securities issued will be under a statutory hold period of four months and one day from the issuance date [6]. Group 5: Company Overview - Viva Gold's Tonopah Gold Project is strategically located in a prominent mining area in Nevada, with a developed high-confidence gold mineral resource and potential for an economically viable open pit project [10]. - The Company is led by experienced professionals, including CEO James Hesketh, who has extensive experience in mining development and construction [10].

Core Viewpoint - Ventripoint Diagnostics Ltd. is conducting a non-brokered private placement to raise up to $500,000 through the issuance of 5,000,000 units at a price of $0.10 per unit, subject to regulatory approval [1][5]. Group 1: Offering Details - Each unit consists of one common share and one common share purchase warrant, with the warrants allowing the purchase of additional shares at $0.13 for 24 months [2]. - The corporation may pay a cash finder's fee and issue finder's warrants up to 8% of the gross proceeds, with each finder's warrant also exercisable at $0.13 for 24 months [3]. - The proceeds from the offering will be allocated to operational costs, sales and marketing, hiring key personnel, and general working capital [4]. Group 2: Regulatory and Compliance Information - All securities issued will be subject to a hold period of four months plus one day from the closing date of the offering [5]. - The securities will not be registered under the U.S. Securities Act of 1933 and cannot be offered or sold in the United States without proper registration or exemption [6]. Group 3: Company Overview - Ventripoint has established itself as a leader in applying AI to echocardiography, with its VMS+ products providing accurate cardiac measurements comparable to MRI [8]. - The technology is a cost-effective alternative that enhances cardiologists' confidence in patient management and is compatible with all ultrasound systems from various vendors, supported by regulatory approvals in the U.S., Europe, and Canada [8].